Myelin Protein Zero-Like 2 (MPZL2) (N-Term) Peptide
Quick Overview for Myelin Protein Zero-Like 2 (MPZL2) (N-Term) Peptide (ABIN8105916)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- MPZL2 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-MPZL2 antibody ( ARP46654_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
-
Background
-
Background Information: Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis. It is highly homologous
Alternative Symbols: EVA, EVA1
-
Molecular Weight
- 22kDa
-
Gene ID
- 10205
-
NCBI Accession
- NP_005788
-
UniProt
- O70255
Target
-